2018: INDUSTRY RE-STRATEGISES BUSINESS PLANS
India is increasingly gaining the much-needed Government focus on expanding affordable health care. This year, India took a giant leap towards providing accessible and affordable healthcare to the common man with the launch of Ayushman Bharat in September, 2018. In parallel, the Government remains committed to establishing India as a global manufacturing hub for medical devices with this sector expected to increase significantly. The new medical device rules which came into force from January 2018 has finally given the medical devices and in-vitro diagnostic devices (IVD) industry a distinctive regulatory identity. Scientific development in India is definitely contributing immensely to improved healthcare, improved devices, diagnostics and much more. Hence companies are re-strategising their business plans appropriately to make difference to the consumers.
The BioSpectrum India edition was launched in March 2003 and is India's first comprehensive biotech business monthly magazine. It provides comprehensive coverage of the exciting happenings in life sciences, which include BioPharma, BioAgriculture, BioInformatics, BioIndustrial, BioSuppliers and BioServices and show cases the emerging Indian entrepreneurships in biotech industry. In a short time BioSpectrum has emerged as the most preferred platform to engage the life sciences industry in India and Asia Pacific. It is also widely accepted by research and academia community. Top key policy makers in the Central and state government use the magazine as a platform to reach out the Indian Biotech Industry. BioSpectrum has columns by Indian's top policy makers, biotechnology professionals, scientists and NGOs. Readers of BioSpectrum are from among the key Policy Makers, Key Executives and the Influencer's in Biotechnology, Pharmaceutical Companies, Research Heads of Clinical Research, Clinical Trials and Contract Mfg Organizations, Educational Institutes, Consultants, Fund Managers etc
